Stock data
Senti Biosciences Holdings, Inc. (SNTI)
Senti Biosciences Holdings, Inc. (SNTI) reported revenue of US$0.02M and net income of -US$61.44M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$0.02M | — | -US$68.78M | -US$61.44M | — |
| 2024 | US$0.00M | — | -US$61.04M | -US$52.79M | — |
| 2023 | US$1.98M | — | -US$92.73M | -US$71.06M | — |
| 2022 | US$3.29M | — | -US$62.08M | -US$58.21M | — |
| 2021 | US$2.29M | — | -US$40.45M | -US$55.32M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$0.02M | -US$12.75M | — |
| 2026-03-31 | US$0.02M | -US$4.22M | — |
| 2025-12-31 | — | -US$14.47M | — |
| 2025-09-30 | — | -US$18.13M | — |
| 2025-06-30 | US$0.00M | -US$14.73M | — |
| 2025-03-31 | US$0.00M | -US$14.11M | — |
| 2024-12-31 | US$0.00M | -US$0.61M | — |
| 2024-09-30 | US$0.00M | -US$28.87M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.